Avalo Therapeutics (AVTX) EBIT Margin (QoQ) (2016 - 2024)
Avalo Therapeutics (AVTX) EBIT Margin (QoQ) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -176,775.00 |
| Dec 31, 2023 | 24,783.00 |
| Sep 30, 2023 | -47,701.00 |
| Jun 30, 2023 | 73,897.00 |
| Mar 31, 2023 | -86,267.00 |
| Dec 31, 2022 | -101,567.00 |
| Sep 30, 2022 | 117,241.00 |
| Jun 30, 2022 | 63,273.00 |
| Mar 31, 2022 | 642,453.00 |
| Dec 31, 2021 | -698,280.00 |
| Sep 30, 2021 | -70,893.00 |
| Jun 30, 2021 | 595,456.00 |
| Mar 31, 2021 | -537,367.00 |
| Dec 31, 2020 | 10,360.00 |
| Sep 30, 2020 | -31,202.00 |
| Jun 30, 2020 | 25,760.00 |
| Mar 31, 2020 | -99,746.00 |
| Dec 31, 2019 | -1,318.00 |
| Sep 30, 2019 | 5,201.00 |
| Jun 30, 2019 | 1,226.00 |